OraSure Technologies stock falls 1.5 percent as stake emerges

Published on 09/25/2026 at 07:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

OraSure Technologies stock stood at USD 3.93 on September 24, 2026, after a new shareholder group disclosed its position. Q2 revenue reached USD 30.6 million and GAAP profit was USD 6.2 million.

OraSure Technologies stock, healthcare, medical instruments, activist investor stake, Nasdaq, Illustration mit AI erstellt.

OraSure Technologies stock (ISIN US68554V1089) stood at USD 3.93 on Nasdaq on September 24, 2026 at 4:00 p.m. ET, down 1.50 percent from the previous close. The immediate market backdrop is a newly disclosed investor group holding 6.4 percent of the company.

Investor group targets value

According to StockTitan, a Schedule 13D filed on September 17, 2026 reported beneficial ownership of 4,408,634 shares, equal to 6.4 percent of the 68,968,627 shares outstanding as of July 31, 2026.

The group includes Islet Management and Yorkville affiliated funds. Its September 11, 2026 agreement covers coordinated filings, discussions with management and the potential nomination of directors at OraSure's 2027 annual meeting. That gives the ownership disclosure a strategic dimension beyond a passive investment.

Profit returns but cash falls

OraSure's operating picture improved in the second quarter. Yahoo Finance reported that Q2 2026 revenue reached USD 30.6 million on August 5, 2026, up 9.7 percent from the prior quarter, while GAAP net income was USD 6.2 million versus a USD 19.7 million loss in Q2 2025.

The comparison is mixed. Total revenue was down 2 percent year over year, while GAAP gross margin rose to 43.5 percent from 42.1 percent. Cash and equivalents stood at USD 161 million at the end of June 2026, compared with USD 199.3 million at the end of 2025, and operating cash use totaled USD 23.8 million in the first half of 2026.

Stock remains below yearly high

OraSure Technologies stock traded between USD 2.08 and USD 4.58 over the 52 weeks through September 24, 2026. The USD 3.93 reference price is USD 0.65 below the yearly high, leaving the activist campaign and the durability of the recent profit turnaround as the two measurable issues shaping the next phase.